Homology Medicines Inc logo

Homology Medicines Inc Share Price (NASDAQ: FIXX)

▲

-0.93

(-100%)

Live

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 25 Mar 2024

Check the interactive Homology Medicines Inc Stock chart to analyse performance

Homology Medicines Inc Key Stats

Check Homology Medicines Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.9347
Open
$0.92
Market Capitalization
$51.4M
Today's Volume
$401.3K
Revenue TTM
$1.2M
EBITDA
$-90.6M
Earnings Per Share (EPS)
$-1.95
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-90.02%

Global Institutional Holdings in Homology Medicines Inc

  • Name

    Holdings %

  • Temasek Holdings Ltd.

    9.74%

  • 5AM Venture Management, LLC

    7.82%

  • Vanguard Group Inc

    3.34%

  • Newtyn Management LLC

    2.41%

  • BlackRock Inc

    1.88%

  • Citadel Advisors Llc

    1.52%

Analyst Recommendation on Homology Medicines Inc Stock

Rating
Trend

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Homology Medicines Inc(by analysts ranked 0 to 5 stars)

About Homology Medicines Inc

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.
Organization
Homology Medicines Inc
Employees
7
CEO
Dr. Paul Alloway J.D., Ph.D.
Industry
Health Technology

Important FAQs about investing in FIXX Stock from India :

What is Homology Medicines Inc share price today?

Homology Medicines Inc share price today is as on . Homology Medicines Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Homology Medicines Inc share?

Homology Medicines Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Homology Medicines Inc stock price today i.e. is trending at , lower by 100% versus the 52 week high.

How to invest in Homology Medicines Inc Stock (FIXX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Homology Medicines Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Homology Medicines Inc Shares .

What is the minimum amount required to buy Homology Medicines Inc Stock (FIXX) from India?

Indian investors can start investing in Homology Medicines Inc (FIXX) shares with as little as ₹88.2013 or $1 (as of September 15, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.01 in Homology Medicines Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025). Learn more about fractional shares .

What are the returns that Homology Medicines Inc has given to Indian investors in the last 5 years?

Homology Medicines Inc stock has given 0.0% share price returns and 19.92% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?